Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma
Brain Pathology · 2023-07 · 33 (4)
DOI: 10.1111/bpa.13153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 07.02.2023. Verfasst von Rui-Chao Chai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Spinal Cord Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Nova Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
H3 K27‐altered diffuse midline glioma is a highly lethal pediatric‐type tumor without efficacious treatments. Recent findings have highlighted the heterogeneity among diffuse midline gliomas with different locations and ages. Compared to tumors located in the brain stem and thalamus, the molecular and clinicopathological features of H3 K27‐altered spinal cord glioma are still largely elusive, thus hindering the accurate management of patients. Here we aimed to characterize the clinicopathological and molecular features of H3 K27M‐mutant spinal cord glioma in 77 consecutive cases. We found that the H3 K27M‐mutant spinal cord glioma, with a median age of 35 years old, had a significantly better prognosis than H3 K27M‐mutant brain tumors. We noticed a molecular heterogeneity of H3 K27M‐mutant spinal cord astrocytoma via targeted sequencing with 34 cases. TP53 mutation which occurred in 58.8% of cases is mutually exclusive with PPM1D (26%) and NF1 (44%) mutations. The TP53 ‐mutant cases had a significantly higher number of copy number variants (CNV) and a marginally higher proportion of pediatric patients (age at diagnosis 10%) are associated with a worse prognosis. Interestingly, the histological type, an independent prognostic factor in multivariate Cox regression, can also stratify molecular features of H3 K27M‐mutant spinal cord glioma, including the RB pathway, KRAS/PI3K pathway, and chromosome arms CNV. In conclusion, although all H3 K27M‐mutant spinal cord diffuse glioma were diagnosed as WHO Grade 4, the histological type, molecular features representing chromatin instability, and molecular alterations associated with accelerated cell proliferative activity should not be ignored in clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, SAR, China.
ORCID-Profile: Rui-Chao Chai, Hui-Yuan Chen, Yong-Zhi Wang
Förderung
- Beijing Nova Program
- National Natural Science Foundation of China
Zitieren
APA
Chai, R. C., Yan, H., An, S. Y., Pang, B., Chen, H. Y., Mu, Q. H., Zhang, K. N., Zhang, Y. W., Liu, Y. Q., Liu, X., Zhao, Z., Jiang, T., Wang, Y. Z., & Jia, W. Q. (2023). Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma. Brain Pathology, 33(4). https://doi.org/10.1111/bpa.13153
Vancouver
Chai RC, Yan H, An SY, Pang B, Chen HY, Mu QH, et al. Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma. Brain Pathology. 2023;33(4). doi:10.1111/bpa.13153
BibTeX
@article{Chai2023,
author = {Chai, Rui-Chao and Yan, Hao and An, Song-Yuan and Pang, Bo and Chen, Hui-Yuan and Mu, Quan-Hua and Zhang, Ke-Nan and Zhang, Yao-Wu and Liu, Yu-Qing and Liu, Xing and Zhao, Zheng and Jiang, Tao and Wang, Yong-Zhi and Jia, Wen-Qing},
title = {Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma},
journal = {Brain Pathology},
year = {2023},
volume = {33},
number = {4},
doi = {10.1111/bpa.13153}
}
EUVIMED